Literature DB >> 1126604

Jaundice due to erythromycin estolate.

M R Lunzer, S N Huang, K M Ward, S Sherlock.   

Abstract

A 43-year-old male developed abdominal pain and jaundice after the administration of erythromycin estolate. The diagnosis was strongly suspected on clinical grounds, but ultimate confirmation depends upon the demonstration of biochemical and morphological alterations after challenge with the drug.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1126604

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


  5 in total

1.  Hepatotoxicity of erythromycin ethylsuccinate in a child.

Authors:  K G Phillips
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

2.  Hepatic reactions to drugs.

Authors:  S Sherlock
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

3.  Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure.

Authors:  J Deutsch; H Wolf; H Becker; B Fuchs; U Goriup; H M Grubbauer; W Muntean; T Popow-Kraupp; D Stünzner
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

4.  Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.

Authors:  E S Zafrani; K G Ishak; C Rudzki
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

5.  Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP.

Authors:  J P Hosker; D P Jewell
Journal:  Postgrad Med J       Date:  1983-08       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.